论文部分内容阅读
目的评价改造球囊在无复流治疗中的效果。方法选取该院心内科2008年3月—2016年1月择期经皮冠状动脉治疗中发生无复流的患者80例,随机分为观察组和对照组,观察组应用改造球囊靶向注射硝普钠,对照组常规经指引导管注射硝普钠,评价给药前后冠状动脉血流、心肌梗死溶栓试分级、心肌组织灌注分级以及不良反应发生情况。结果观察组冠状动脉血流、心肌梗死溶栓试分级、心肌组织灌注分级和不良反应发生方面显著优于对照组。结论改造球囊在无复流治疗中有效、经济,有推广价值。
Objective To evaluate the effect of reconstructed balloon on no-reflow therapy. Methods Eighty patients with no-reflow occurred during the elective percutaneous coronary intervention from March 2008 to January 2016 in our hospital were randomly divided into observation group and control group. In the observation group, Normal sodium and control group were routinely injected sodium nitroprusside through the guiding catheter to evaluate coronary blood flow, myocardial infarction thrombolysis grade, myocardial tissue perfusion grade and adverse reaction before and after administration. Results The observation group was significantly superior to the control group in coronary blood flow, myocardial infarction thrombolysis grade, myocardial perfusion grade and adverse reactions. Conclusion Modified balloon in the treatment of no-reflow is effective, economical and has promotion value.